Efficacy Profile News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Dublin, Feb. 21, 2024 (GLOBE NEWSWIRE) -- The

New Data Showing that Transgene and NEC's Individualized Cancer Vaccine TG4050 Induces Strong and Specific Immune Responses against Tumors Presented at AACR 2023 - New Phase I data confirm promising immunogenicity and efficacy profile of TG4050, an ...

Company Provides Comprehensive Clinical Update from Phase 1/2 TrialTuspetinib Continues to Deliver Single Agent Responses in r/r AML PatientsTuspetinib...

Gilead to Present Data Across Viral Hepatitis and Liver Fibrosis at The Liver Meeting® 2022, Reinforcing Gilead as a Leader in Addressing Treatment Needs for People Living With Liver Disease

A small percentage of something that's common can result in a lot of hospitalations and deaths. you know, it's not just about deaths. it's hospitalations, icu admissions. first of all about, 1,000 children less than 18 years of age died. that's certainly far more than we would see every year from measles or influenza or chicken pox for which we also have vaccines. this vaccine has been out in millions and millions of children. you know its safety parole file. you know its efficacy profile. there's no more secrets anymore with these vaccines so let's get our kids vaccinated. >> doctor, great to...